About Us
UV Clinical is a company specialized in the development of devices using ultra-violet light
UV Clinical
About UV Clinical
UV Clinical is a company specialized in the development of devices using ultra-violet light emitting diodes (UVC – LED) for disinfection of medical tubing. Our competences and experience with the disinfection capabilities of this future new UVC LED disinfection technology are gained through pioneering scientific work starting with adoption and experiments with early market UVC LED technologies.
Management
The company was founded in 2017 by Jimmy Bak as a spin-off from the Technical University of Denmark (DTU). In the following years the company have been busy with development of prototypes of UVC light source and UVC light-guide. This has been followed by proof of concept and a 6-log unit reduction of selected pathogens inside endotracheal tubes and CVC extension line tube part (in vitro). In 2021 Rolf H. Sprunk-Jansen takes over the majority of the shares and becomes Chief Executive Officer focusing on making a world-class medical device together with founder Jimmy Bak.
Management Team
Rolf H. Sprunk-Jansen
CEO & Largest Shareholder
M.Sc. Business Administration
Current Role
Rolf H. Sprunk-Jansen joined UV Clinical A/S in August 2021 as CEO and majority shareholder. He is responsible for the company’s overall management, strategic direction, and commercial development. Under his leadership, UV Clinical is advancing its patented medical technology platform toward regulatory approval and market launch.
Expertise
Prior to joining UV Clinical, Rolf was co-founder and CEO of the high-tech lighting company LED iBond International A/S. Over nine years, he led the company from inception to a successful listing on Nasdaq First North. During this period, he spearheaded multiple funding rounds, built international sales channels, established a fully automated production facility for the company’s prizewinning luminaires, and launched several spin-off ventures.
Before that, Rolf co-founded a herbal medicine company in 2003. As Chief Executive Officer, he set up a corporate headquarters in Denmark with an operations center in Lithuania and grew the company’s reach by establishing distributor networks in Estonia, Latvia, Sweden, and Poland. Under his direction, the company successfully introduced nine products in five countries and received Frost & Sullivan’s Entrepreneurial Company Award in 2005.
With 25 years of executive experience, Rolf is recognized as a dynamic and results-driven leader with a proven track record in raising capital, scaling high-tech businesses, driving innovation, and building high-performance teams. He has held senior leadership roles in several technology and industrial companies, including FOSS and Nomeco.
Jimmy Bak
CTO & Founder
Founder, responsible for technology and IPR since 2017 and has worked with this technology since 2009. Jimmy has a M. Sc. in chemistry and physics and a Master degree in applied statistics. Background in spectroscopy and optics at Risø National Lab and DTU (Technical University of Denmark). With his strong and broad academic background, Jimmy has started the scientific work with UV-C LED disinfection in the clinical area. He has published several scientific papers.
Board of Directors
Helge Holm-Larsen
Chairman of the Board of Directors
Skilled C-level executive and board member in high tech start up companies, especially within automation, clean tech and medical device. Degrees in Chemical Engineering (DTU) and International Trade (CBS). Selected key roles: CEO, SDI – SDI invests in innovative early stage tech-based companies within Industry, Cleantech, IKT & Big Data and Medical Device. SDI holds ownership positions in 28 companies. Former Chairman of the Board, FOM Technologies. FOM Specializes in machines and equipment for slot-die coating of functional materials. FOM Technologies was the most successful IPO at Nasdaq First North in 2020. In 2021, FESE selected FOM Technologies the best European IPO in the Rising Star Category. Board member, Vulcur Medtech. Vulcur Medtech is developing FlashHeal, a medical device for painless treatment for chronic wounds to help prevent amputations among diabetic patients and other chronic wound patients.
Emilio de la Guardia
Member of the Board of Directors
Double Degree in Law and History from the University of Navarra, MBA McGill University, Master in EEC Law from the College of Europe (Bruges). More than 30 years´ experience in the finance sector in corporate financing, structuring of project financing operations and venture capital; investment banking (mergers and acquisitions, LBOs and MBOs). Proven track record in finance leadership in lending, structuring, venture capital, private equity and Mergers and Acquisitions for public, private and hybrid entities. Private equity investor and startup-companies entrepreneur, founder, and principal as well. Joined the European Investment Bank (EIB) in 1987 where he has been responsible for financing operations in different countries: Italy, France, United Kingdom, Morocco, Portugal, Spain. This included finance projects for Airbus, Euro Disney program and the Euro Tunnel. Further, in JASPERS (joint EIB/EU/EBRD Commission initiative) he was Country manager for Hungary, Romania, Bulgaria, Cyprus, Malta, extending later as well to Poland, Czech Republic and Baltic States (Estonia, Lithuania, and Latvia). 5 years in COFIDES (Bilateral Promotion Agency of Spain) as General Delegate for Morocco and North Africa., based in Casablanca. Founding partner and Director of APD Morocco. Partner and Vice President of Maderfibra Internacional (industrial wood packaging company) in Spain and Dubai. Currently member of the Board of industrial companies and investment funds in Luxembourg.
Jimmy Bak
CTO & Founder
Founder, responsible for technology and IPR since 2017 and has worked with this technology since 2009. Jimmy has a M. Sc. in chemistry and physics and a Master degree in applied statistics. Background in spectroscopy and optics at Risø National Lab and DTU (Technical University of Denmark). With his strong and broad academic background, Jimmy has started the scientific work with UV-C LED disinfection in the clinical area. He has published several scientific papers.
Rolf H. Sprunk-Jansen
CEO & Largest Shareholder
M.Sc. Business Administration
Current Role
Rolf H. Sprunk-Jansen joined UV Clinical A/S in August 2021 as CEO and majority shareholder. He is responsible for the company’s overall management, strategic direction, and commercial development. Under his leadership, UV Clinical is advancing its patented medical technology platform toward regulatory approval and market launch.
Expertise
Prior to joining UV Clinical, Rolf was co-founder and CEO of the high-tech lighting company LED iBond International A/S. Over nine years, he led the company from inception to a successful listing on Nasdaq First North. During this period, he spearheaded multiple funding rounds, built international sales channels, established a fully automated production facility for the company’s prizewinning luminaires, and launched several spin-off ventures.
Before that, Rolf co-founded a herbal medicine company in 2003. As Chief Executive Officer, he set up a corporate headquarters in Denmark with an operations center in Lithuania and grew the company’s reach by establishing distributor networks in Estonia, Latvia, Sweden, and Poland. Under his direction, the company successfully introduced nine products in five countries and received Frost & Sullivan’s Entrepreneurial Company Award in 2005.
With 25 years of executive experience, Rolf is recognized as a dynamic and results-driven leader with a proven track record in raising capital, scaling high-tech businesses, driving innovation, and building high-performance teams. He has held senior leadership roles in several technology and industrial companies, including FOSS and Nomeco.
Advisory Board
Marie-Louise Moes Struckmann
Marie-Louise graduated as a doctor from the University of Copenhagen in 1992 and has undergone extensive training at the Copenhagen hospitals in surgery and not least vascular surgery. She became a PhD in 1998, MD. in 2003 and a specialist in vascular surgery in 2008 at Rigshospitalet. Active in research for almost 30 years and been research-responsible department doctor at Aalborg University Hospital 2009-2012 and Chief Physician of the Varicose veins clinic at Nyborg Hospital under Odense University Hospital 2012-2014. Since then, she has been in varicose veins clinics in Næstved, Malmø, Gothenburg and Stockholm. Marie-Louise is now running her own veins clinic in Kongens Lyngby, Denmark.
Mette Hvolbøll
Mette has extensive clinical experience. Since she graduated from Slagelse Nursing School in 1997, Mette has specialized in haemodialysis and nephrology. She has worked with numerous dialysis catheter generations in clinical settings and has seen the evolution of standards for their maintenance and hygiene. In 2017, Mette helped establish the self-service haemodialysis unit in a Danish Hospital, where she now serves as the daily manager. She is a dialysis specialist, focusing on planning, teaching, and dialysis treatment of chronic kidney patients under optimal hygienic conditions.
Dr. Bhupendra Gandhi
Dr. Bhupendra Gandhi, the leading kidney doctor in India, is a highly respected nephrologist. M.B.B.S. from Grant Medical College, University of Bombay (1965), American Board of Internal Medicine (1972) and American Board in Subspecialty of Nephrology (1974). Founded the department of nephrology at Breach Candy Hospital. He is also the Honorary Nephrologist at Sir HN Reliance Foundation and Research Centre. Further, Senior Consultant Nephrologist, Breach Candy Hospital, Mumbai (since 1975). Dr. Gandhi’s extensive education and significant roles in both the United States and India reflect his dedication and expertise in nephrology. His contributions, particularly in establishing the nephrology department at Breach Candy Hospital, have had a lasting impact on the medical community.
Ganesh Malhotra
Ganesh is a seasoned professional with an MBA from XIM India and over twenty years of expertise in International Corporate Finance and Investment Banking. Founding Director of Phoenix Consultancy Enterprises Ltd / Silver Star Capital Services FZE / Griffin Oil FZE and Power Dynamic FZE in Dubai. His career also includes roles at MF Global and Merrill Lynch. Ganesh is on the Board of various companies including the financial institution LKP Securities Ltd, listed on the Bombay Stock Exchange in India
Søren Ulstrup
Søren has spent his entire career in plastic, first as an owner/CEO of the family owned Ulstrup Plast, later (after the merger into SP group) as an Executive Vice President at SP Group. Søren joins the UV Clinical Advisory Board to contribute with comprehensive and hands-on understanding of injection moulding and extrusion supply chain and manufacturing issues and with requirements for plastic based medical devices and development of medical devices in general. Selected key roles: - Chairman of the Board, Plastic Industry in Denmark - Executive VP, SP Group A/S - Senior positions of trust in Danish Industry and various boards, including Coreplast and SP Group subsidiaries - Chairman of the Board in Ulstrup Invest - Investor in several early stage tech companies, including pre-IPO investor in FOM Technologies, FESE best IPO of 2020 (Rising Star) Søren has also joined UV Clinical A/S as an investor.
Gilles Trancart
Gilles Trancart has more than 35 years of experience as top executive in the financial sector. After a PHD in Economics and Statistics from ENSAE (France), Gilles started his career at the French Central Bank as an inspector, specialised in the supervision of market activities. As a real entrepreneur, he joined ODDO BHF as general partner and contributed to the fantastic growth of the company with several M&A deals. With Credit Agricole and Lazard, he got the experience of global position with the management of teams in more than 40 countries, including the US. Today, Gilles brings his top management experience to several companies as board member or investor in startups. Selected key roles: - Independent board member of Inversis, bank in Madrid - Independent board member of MCB, bank in Mauritius - Independent board member of Antwort, P-E fund in Luxembourg - Advisory board of Onbrane/Nasdaq - Advisory board of Imescia (medical) - Advisory board of CBS (French navy seals supplier) - Advisory board of IMGA (Asset Manager in Portugal) - Senior Advisor of Accuracy (consulting) - Senior Advisor of UV Clinical A/S Gilles is also shareholder of UV Clinical A/S.
Peter Mørch Eriksen
Peter Mørch Eriksen has more than 20 years of experience in management and strategy work in the medical technology and life-science industries. Peter, who has a master’s degree from CBS, has worked as CEO and held other senior positions within BioPorto, Sense, Medtronic, Brüel & Kjær, and with his extensive experience has created growth, restructuring and secured financing in technology-intensive international organizations. Peter Mørch Eriksen has top management experience in the life-science industry, where he has worked in large listed multinational companies as well as in startups, from which he has extensive experience in strategy work, sales, branding, marketing, finance, and management and contributed to the development of these companies. Peter Mørch Eriksen Holds Positions In The Following Companies: - Chairman of the board, Fluoguide A/S (First North, Nasdaq Sweden) - Chairman of the board, Monsenso A/S (First North, Nasdaq Denmark) - Member of the board, Blue Vision A/S (Nasdaq Denmark) - Member of the board, BioPorto A/S (Nasdaq Denmark) - Chairman of the board, My Blue Label A/S (Private) - Advisory Board, Lund University and Diabetes center (Sweden) - Advisory Board, Medical Device & Diagnostics at Cincinnati Children’s Hospital (USA) - Advisory Board, UV Clinical A/S